Avalon GloboCare Corp (NASDAQ:ALBT) announced that it has engaged ChtrBx, a marketing and branding company, to develop a marketing launch plan for KetoAir in North America, South America, the United Kingdom (UK) and the European Union (EU).
The developer of innovative cell-based technology, cellular therapy and precision diagnostics said KetoAir functions as a companion diagnostic and monitoring device, combined with an artificial intelligence (AI) nutritionist consultation for ketogenic dietary management.
"ChtrBx’s founder, Roy Edmondson, has been successful in orchestrating and launching multimedia campaigns globally for major brand names such as Levi Strauss & Co (NYSE:LEVI), Kodak, BestBuy, Rocawear, Absolut and many more," Avalon GloboCare CEO David Jin said in a statement.
"We look forward to leveraging ChtrBx’s expertise to develop and execute an effective marketing program that we believe will yield positive results for KetoAir," he added.
Edmondson noted that ChtrBx plans to soft launch KetoAir in 2024 followed by a hard launch in 2025.
In April, Avalon announced that it has partnered with Qi Diagnostics to exclusively distribute the KetoAir in North America, South America, the UK, and the EU.
Avalon GloboCare is a commercial-stage company dedicated to developing and delivering innovative, transformative, precision diagnostics and clinical laboratory services.